Middle East MED-EL Observatory Study
Launched by MED-EL ELEKTROMEDIZINISCHE GERÄTE GESMBH · Mar 19, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Middle East MED-EL Observatory Study is a research project aimed at understanding how effective cochlear implants are over the long term. Cochlear implants are devices that help people with hearing loss by stimulating the auditory nerve. This study will collect health information from children and adults who have received or will receive a MED-EL cochlear implant. The information will be gathered in a systematic way, meaning it will be organized and collected regularly to help researchers see how patients are doing over time.
To join the study, participants must have a MED-EL cochlear implant or be planning to get one. They will need to provide written permission for their health information to be used in the study. The study is open to everyone, regardless of age or gender. Participants can expect that their information will be kept private and secure, and they will receive care as usual during their treatment. This study is important because it aims to gather more data on cochlear implants, which could lead to better outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects who are implanted or will be implanted with a MED-EL CI system.
- • Signed written informed consent for data collection for registry purposes.
- Exclusion Criteria:
- • Lack of compliance with any inclusion criteria.
- • Subjects not receiving a MED-EL CI system due to medical or personal reasons after having consented.
- • Anything that, in the opinion of the Investigator would place the subject at increased risk or preclude the subject's full compliance with or completion of the registry procedures.
About Med El Elektromedizinische Geräte Gesmbh
MED-EL Elektromedizinische Geräte GmbH is a leading innovator in the field of medical technology, specializing in advanced hearing solutions. Established in 1989, the company focuses on developing implantable hearing devices and comprehensive rehabilitation solutions aimed at improving the quality of life for individuals with hearing loss. With a commitment to research and development, MED-EL collaborates with healthcare professionals and academic institutions to drive clinical trials that enhance auditory care and foster groundbreaking advancements in hearing healthcare. Their dedication to innovation and excellence positions MED-EL as a pivotal player in the global medical device industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Riyadh, , Saudi Arabia
Riyad, , Saudi Arabia
Patients applied
Trial Officials
Abdulrahman Ahmed Alsanosi, Prof.
Principal Investigator
King Abdullah Ear Specialist Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials